Citing costs, East Bay drug facility closing, cutting 550 jobs, after big merger

Amneal Pharmaceuticals Inc. will shed 550 manufacturing, research and office jobs as it shuts down the Hayward facilities of the former Impax Laboratories after its merger with the East Bay company this week created the nation's fifth-largest generic drug company. Amneal (NYSE: AMRX) leaders were vague on a conference call Monday, when its $6 billion merger with Impax was completed, about the fate of the East Bay facilities. But Friday the company said a "comprehensive analysis" of its current and…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news